Access to Breast Cancer Diagnosis Act of 2025

Summary of HR 3037: Access to Breast Cancer Diagnosis Act of 2025

Bill Number: HR 3037

Title: Access to Breast Cancer Diagnosis Act of 2025

Status: Introduced in House

Introduced Date: April 28, 2025

Classification: Bill

Purpose and Intent

The Access to Breast Cancer Diagnosis Act of 2025 aims to improve access to timely and accurate breast cancer diagnosis for individuals across the United States. The bill seeks to address disparities in healthcare access and ensure that all patients receive the necessary diagnostic services without undue financial burden.

Key Provisions

While the specific text of the bill is not provided, the following key provisions are expected based on the bill's title and purpose:

• Enhanced Coverage: The bill likely proposes to mandate that health insurance plans cover comprehensive breast cancer diagnostic services, including mammograms, biopsies, and other necessary imaging tests.

• Cost Sharing Reduction: It may include provisions to limit out-of-pocket costs for patients seeking breast cancer diagnostic services, making it more affordable for individuals to access these critical tests.

• Patient Education: The bill may also emphasize the importance of patient education regarding breast cancer symptoms and the significance of early detection.

• Equity in Access: The legislation is expected to focus on reducing barriers to access for underserved populations, including low-income individuals and those in rural areas.

Affected Parties

The Access to Breast Cancer Diagnosis Act of 2025 would primarily affect:

• Patients: Individuals seeking breast cancer diagnosis and treatment, particularly those facing financial or geographic barriers.

• Healthcare Providers: Medical professionals and institutions providing diagnostic services who may need to adapt to new coverage requirements.

• Insurance Companies: Health insurers that will need to comply with the new mandates regarding coverage and cost-sharing.

Legislative Process and Timeline

• Introduced: The bill was introduced in the House on April 28, 2025.

• Committee Referral: Upon introduction, HR 3037 was referred to the Committee on Energy and Commerce and the Committee on Ways and Means for consideration. The Speaker of the House will determine the period for review by these committees.

• Companion Bill: There is a related companion bill, S 1500, which is expected to mirror the provisions of HR 3037 in the Senate.

Conclusion

The Access to Breast Cancer Diagnosis Act of 2025 represents a significant step towards improving healthcare access for breast cancer diagnosis. By mandating coverage and reducing financial barriers, the bill aims to ensure that all individuals have the opportunity for early detection and treatment of breast cancer, ultimately contributing to better health outcomes. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and impact.